Biotechnology Quotes

A Machine to Make a Future is an insightful and creative contribution to the literature--both scholarly and journalistic--on contemporary genomics. By 'experimenting' with narrative genre, the authors hope to generate different insights into the world of genomics and biotechnology than ones generally presented in existing accounts. They succeed at that goal, providing an account that is ethnographically rich and analytically open to a world whose structure, implications, and outcomes are very much in the making.

Even to this day, the government, the FDA is refusing to use the sophisticated biotechnology to evaluate the contaminants in the vaccines such as the polio vaccines that they are administering. I think (people) would be appalled that some of the vaccines that are currently being used are still laced with viruses.

How do commercial interests usually protect themselves from liability claims? Through insurance. In fact, in our society, the litmus test for safety is insurance. You can be insured for almost anything if you pay enough for the premium, but if the insurance industry isn't willing to bet its money on the safety of [biotechnology], it means the risks are simply too high or too uncertain for them to take the gamble.

No amount of outer technology, no amount of computers and biotechnology and nanotechnology is going to stop the continuation of warfare and racism and environmental destruction. What's called for on the Earth at this time is really a change of heart ... the question is really not the future of humanity, but the presence of eternity.

In an interview, last year in the journal Biotechnology Healthcare, Dr. Berwick said, “The decision is not whether or not we will ration care — the decision is whether we will ration with our eyes open.

What intrigued me most was not the technology as such but the questions about the human goods, the fundamental human values and virtues that are raised by debates over biotechnology.

If I were 21 years old, I would go into biotechnology or genetic engineering.

I see a bright future for the biotechnology industry when it follows the path of the computer industry, the path that von Neumann failed to foresee, becoming small and domesticated rather than big and centralized.

If only the human body could handle trauma as well as biotechnology stocks do.

The way we're really going to grow the economy is to invest in people, to invest in innovation, to have the federal government put money in the kind of research that will create the new high-technology, bio-technology industries that will create the millions of new jobs.

I'm very interested in the impact of biotechnology on the way people live.

There are other dimensions of biotechnology. If you think of biotechnology like the Internet, it's not a category - it's an infrastructure that can be deployed to sustain or disrupt. In health care, the most complex problems at the high end have to be dealt with in a problem-solving mode by the best, most experienced physicians you can find.

Almost everybody is enthusiastic about the promise of biotechnology to cure disease and to relieve suffering.

We didn't stay in the caves. We haven't stayed on the planet. With biotechnology, gene sequencing, we are not going to even stay within the limitations of biology.

A permanent base on Mars would have a number of advantages beyond being a bonanza for planetary science and geology. If, as some evidence suggests, exotic micro-organisms have arisen independently of terrestrial life, studying them could revolutionise biology, medicine and biotechnology.

If you think about brewing, it is biotechnology. And I would say that I was a technologist at heart. So whether I... fermented beer or whether I fermented enzymes, the base technology was the same.

Rest assured, the government is ready to support and enhance the competitiveness of the biotechnology industry.

‎By 2100, our destiny is to become like the gods we once worshipped and feared. But our tools will not be magic wands and potions but the science of computers, nanotechnology, artificial intelligence, biotechnology, and most of all, the quantum theory.

I started thinking of digital imaging, not photography, in 1994 as it seemed the most appropriate way to deal with ideas of biotechnology and advertising. My practice is conceptual.

In most instances, biotechnology, though a radically different approach, is a sustaining technology: It's a dramatically improved way of targeting problems that we hadn't been able to solve with the conventional approach of mainstream pharmaceutical companies.

A whole new series of technologies like biotechnology, virtual reality, and super-computerization are appearing now that are leading us away from our nature-based roots.

I want American Dream growth - lots of new businesses, well-paying jobs, and American leadership in new industries, like clean energy and biotechnology.

America and Japan are the two leading world economies in terms of technology and innovative products. And in software, information-age technology and biotechnology the U.S. has an amazing lead.

Green is not just about renewable energy. It's also about creating a new direction for the whole economy. This requires government to step up, not step back, creating the kinds of mission-oriented public organizations that will enable us to tackle climate change - as ambitious as those that got us to the moon. It also requires the financial sector to be less short-term since we know that short-term finance has distorted incentives and directions in areas like biotechnology.

We have the means right now to live long enough to live forever. Existing knowledge can be aggressively applied to dramatically slow down aging processes so we can still be in vital health when the more radical life-extending therapies from biotechnology and nanotechnology become available. But most baby boomers won't make it because they are unaware of the accelerating aging process in their bodies and the opportunity to intervene.

The risk of an investment is described by both the probability and the potential amount of loss. The risk of an investment-the probability of an adverse outcome-is partly inherent in its very nature. A dollar spent on biotechnology research is a riskier investment than a dollar used to purchase utility equipment. The former has both a greater probability of loss and a greater percentage of the investment at stake.

Skills training and industry-preparedness are the distinct advantages these students have. At the completion of their degree they have been trained to be biotechnology professionals.

US academic institutions are being bought via funding by biotechnology firms which exert a vice-like grip on the US government.